Simultaneous endoscopic third ventriculostomy and ventriculoperitoneal shunt for infantile hydrocephalus

Kyu-Won Shim1, Dong-Seok Kim, Joong-Uhn Choi

  • 1Department of Neurosurgery, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.

Insights

Simultaneous endoscopic third ventriculostomy and ventriculoperitoneal shunt (ETV/VPS) implantation offers a higher success rate for infant hydrocephalus compared to VPS alone. This combined approach may be the preferred treatment for infants under one year old.

Area of Science:

  • Neurosurgery
  • Pediatric Surgery
  • Medical Technology

Background:

  • Hydrocephalus is a common condition in infants requiring surgical intervention.
  • Ventriculoperitoneal shunts (VPS) and endoscopic third ventriculostomy (ETV) are established treatments.
  • Simultaneous ETV and VPS implantation is a less commonly studied approach.

Purpose of the Study:

  • To compare the effectiveness of simultaneous ETV and VPS implantation versus VPS alone in infants with hydrocephalus.
  • To evaluate shunt success rates and complication profiles for both treatment modalities.

Main Methods:

  • Retrospective analysis of 111 hydrocephalic infants treated between 1995 and 2006.
  • Comparison of a group undergoing simultaneous ETV and VPS (31 infants) with a group undergoing VPS only (45 infants).
  • Assessment of pre- and postoperative ventricular index, shunt failure rates, and complications over a mean follow-up of 53.23 to 75.98 months.

Main Results:

  • The simultaneous ETV plus VPS group demonstrated a higher success rate (83.9%) compared to the VPS only group (68.9%).
  • The ETV plus VPS group experienced fewer complications, including infections and shunt obstructions.
  • Both groups showed statistically significant improvement in the ventricular ratio post-surgery.

Conclusions:

  • Simultaneous ETV and VPS implantation is a more effective treatment for infant hydrocephalus than VPS alone.
  • This combined procedure is recommended as a first-line treatment for hydrocephalic infants under one year of age.
Abstract

Related Concept Videos